IndraLab

Statements

USP46 activates 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. 1 / 1

| 1

➶

reach

"In contrast to hypoxic conditions, targeting of Usp46 increased MTT viability under normoxic conditions."

36313646

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP46 activates 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. 1 / 1

INDRA sources:

Databases

Reading